Earlier quoted context omitted.
Yeah it's not really researchers that I'm worried about, it's their bosses.
Can you provide an example of a treatment people would like that 'big pharma' wouldn't produce because they couldn't make a profit on it? This is such a ridiculous argument, IMO. As a thought experiment consider something like cancer treatment. If some pharma company researcher found a way to 100% prevent or reverse cancer, why would the company hide that? In the best case, they could make a ton of money from it by s…
I like to write and publish books, but only because I know that several thousand people are going to buy them (yeah, humblebrag...). I wouldn't bother with them if my audience was two orders of magnitude smaller. It is just not worth the hassle.
Similarly, most programmers here probably work on projects used by thousands at least as well. Few people will put hours and energy into something that will only be used by, say, three users.
Rare diseases suffer from the same problem. The cost of development of drugs under current regulatory regime is high and in case of rare disease, cannot be amortized later over a huge set of patients. Moreover, most promising drugs actually fail in human trials, but the costs are already incurred.